Cronograma de promoção Relay Therapeutics, Inc.
Agenda avançada
Gráfico simples
Sobre a empresa
Relay Therapeutics, Inc. работает как компания, специализирующаяся на прецизионных медицинских препаратах. Он занимается преобразованием процесса открытия лекарств с первоначальным акцентом на расширении терапевтических открытий малых молекул в целевой онкологии.
Mais detalhes| P/BV | 2.37 |
|---|---|
| EV/EBITDA | 0.2109 |
| EBITDA | -0.0812 |
| Цена ао | 6.42 |
| P/S | 21.87 |
| Сайт | http://www.relaytx.com |
| Число акций ао | 0.12258 млрд |
| P/E | 17.31 |
| Выручка | 0.0827 |
| Див.доход ао | 0 |
| ISIN | US75943R1023 |
| Валюта | usd |
| IPO date | 2020-07-16 |
| Sector | Health Care |
| Industry | Biotechnology |
| Валюта отчета | usd |
| Alteração de preço por dia: | 0% (4.86) |
|---|---|
| Alteração de preço por semana: | +1.25% (4.8) |
| Alteração de preço por mês: | -19.27% (6.02) |
| Alteração de preço em 3 meses: | -28.84% (6.83) |
| Mudança de preço em seis meses: | -22.86% (6.3) |
| Mudança de preço por ano: | -40.44% (8.16) |
| Mudança de preço em 3 anos: | -83.4% (29.28) |
| Mudança de preço desde o início do ano: | -55.86% (11.01) |
|
|
Subestimação
|
Eficiência
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Obrigação
|
Impulso de crescimento
|
|||||||||||||||||||||||||||||||||||||
| Data da transação | Data de divulgação | Insider | Tipo | Preço | Volume | Quantidade | Compartilhe até, % | Compartilhe depois, % | Documento |
|---|---|---|---|---|---|---|---|---|---|
| 28.10.2024 | 30.10.2024 | Adams Brian Chief Legal Officer |
Oferta | 6.06 | 9 890 | 1632 | 0 | 0 | link |
| 28.10.2024 | 28.10.2024 | THOMAS J CATINAZZO Officer |
Comprar | 6.06 | 30 936 | 5105 | 0 | 0 | link |
| 27.09.2024 | 01.10.2024 | Adams Brian Chief Legal Officer |
Oferta | 7.51 | 2 215 | 295 | 0 | 0 | link |
| 27.09.2024 | 01.10.2024 | Bergstrom Donald A President, R&D |
Oferta | 7.51 | 4 866 | 648 | 0 | 0 | link |
| 27.09.2024 | 01.10.2024 | Catinazzo Thomas Chief Financial Officer |
Oferta | 7.46 | 48 169 | 6457 | 0 | -0.01 | link |
| 27.09.2024 | 01.10.2024 | Rahmer Peter See remarks |
Oferta | 7.51 | 1 840 | 245 | 0 | 0 | link |
| 10.06.2024 | 12.06.2024 | Rubin Jami Director |
Comprar | 5.04 | 212 900 | 42242 | 0 | 0.04 | link |
| 29.04.2024 | 29.04.2024 | Bergstrom Donald A President, R&D |
Oferta | 6.38 | 17 137 | 2686 | 0 | 0 | link |
| 29.04.2024 | 29.04.2024 | Catinazzo Thomas Chief Financial Officer |
Oferta | 6.38 | 10 814 | 1695 | 0 | 0 | link |
| 29.04.2024 | 29.04.2024 | Adams Brian Chief Legal Officer |
Oferta | 6.38 | 10 355 | 1623 | 0 | 0 | link |
| 29.04.2024 | 29.04.2024 | Rahmer Peter See remarks |
Oferta | 6.38 | 8 581 | 1345 | 0 | 0 | link |
| 27.03.2024 | 29.03.2024 | Adams Brian Chief Legal Officer |
Oferta | 7.7 | 2 680 | 348 | 0 | 0 | link |
| 27.03.2024 | 29.03.2024 | Rahmer Peter See remarks |
Oferta | 7.7 | 2 295 | 298 | 0 | 0 | link |
| 27.03.2024 | 29.03.2024 | Bergstrom Donald A President, R&D |
Oferta | 7.7 | 5 891 | 765 | 0 | 0 | link |
| 27.03.2024 | 29.03.2024 | Catinazzo Thomas Chief Financial Officer |
Oferta | 7.7 | 2 680 | 348 | 0 | 0 | link |
| 27.06.2023 | 28.06.2023 | Adams Brian Chief Legal Officer |
Oferta | 12.12 | 3 563 | 294 | 0 | 0 | link |
| 27.06.2023 | 28.06.2023 | Bergstrom Donald A President, R&D |
Oferta | 12.12 | 7 842 | 647 | 0 | 0 | link |
| 27.12.2022 | 28.12.2022 | Adams Brian Chief Legal Officer |
Oferta | 14.49 | 4 275 | 295 | 0 | 0 | link |
| 27.12.2022 | 28.12.2022 | Bergstrom Donald A President, R&D |
Oferta | 14.49 | 14 200 | 980 | 0 | 0 | link |
| 27.12.2022 | 28.12.2022 | Catinazzo Thomas Chief Financial Officer |
Oferta | 14.49 | 6 448 | 445 | 0 | 0 | link |
| 13.10.2022 | 13.10.2022 | Patel Sanjiv President and CEO |
Oferta | 20.58 | 288 120 | 14000 | 0 | -0.01 | link |
| 11.10.2022 | 13.10.2022 | Patel Sanjiv President and CEO |
Oferta | 21.36 | 299 040 | 14000 | 0 | -0.01 | link |
| 27.09.2022 | 29.09.2022 | Adams Brian Chief Legal Officer |
Oferta | 22.73 | 6 683 | 294 | 0 | 0 | link |
| 27.09.2022 | 29.09.2022 | Bergstrom Donald A President, R&D |
Oferta | 22.73 | 22 184 | 976 | 0 | 0 | link |
| 08.09.2022 | 08.09.2022 | Bergstrom Donald A President, R&D |
Oferta | 30 | 750 000 | 25000 | 0 | -0.02 | link |
| 08.09.2022 | 08.09.2022 | Bergstrom Donald A President, R&D |
Comprar | 4.12 | 103 000 | 25000 | 0 | 0.02 | link |
| 08.09.2022 | 08.09.2022 | Catinazzo Thomas Chief Financial Officer |
Oferta | 30 | 787 710 | 26257 | 0 | -0.02 | link |
| 01.09.2022 | 01.09.2022 | Bergstrom Donald A President, R&D |
Oferta | 23.07 | 186 867 | 8100 | 0 | -0.01 | link |
| 01.09.2022 | 01.09.2022 | Bergstrom Donald A President, R&D |
Comprar | 4.12 | 33 372 | 8100 | 0 | 0.01 | link |
| 24.08.2022 | 25.08.2022 | Bergstrom Donald A President, R&D |
Oferta | 25 | 375 000 | 15000 | 0 | -0.01 | link |
| 24.08.2022 | 25.08.2022 | Bergstrom Donald A President, R&D |
Comprar | 4.12 | 61 800 | 15000 | 0 | 0.01 | link |
| 24.03.2022 | 28.03.2022 | Bergstrom Donald A President, R&D |
Oferta | 30 | 300 000 | 10000 | 0 | -0.01 | link |
| 24.03.2022 | 28.03.2022 | Bergstrom Donald A President, R&D |
Comprar | 4.12 | 41 200 | 10000 | 0 | 0.01 | link |
| 24.03.2022 | 28.03.2022 | Catinazzo Thomas Chief Financial Officer |
Oferta | 30 | 398 580 | 13286 | 0 | -0.01 | link |
| 24.03.2022 | 28.03.2022 | Catinazzo Thomas Chief Financial Officer |
Comprar | 4.12 | 54 738 | 13286 | 0 | 0.01 | link |
| Instituições | Volume | Compartilhar, % |
|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 27904963 | 21.27 |
| Vanguard Group Inc | 10650387 | 8.12 |
| Blackrock Inc. | 9573423 | 7.3 |
| Price (T.Rowe) Associates Inc | 8581167 | 6.54 |
| Casdin Capital, LLC | 7387943 | 5.63 |
| JP Morgan Chase & Company | 6065595 | 4.62 |
| Bellevue Group AG | 5936082 | 4.53 |
| State Street Corporation | 4903578 | 3.74 |
| BVF Inc. | 3970045 | 3.03 |
| ArrowMark Colorado Holdings LLC | 3914246 | 2.98 |
| ETF | Compartilhar, % | Rentabilidade para o ano, % | Dividendos, % |
|---|---|---|---|
| Avantis U.S Small Cap Equity ETF | 0.11461 | 27.774101036841 | 1.68271 |
| Avantis Responsible U.S. Equity ETF | 0.00001 | 26.778312788906 | 1.45257 |
| Avantis U.S. Equity ETF | 0.00174 | 32.224830464267 | 1.59151 |
| Virtus LifeSci Biotech Clinical Trials ETF | 0.75923 | 63.040315712071 | 0.33 |
| JPMorgan BetaBuilders U.S. Small Cap Equity Fund | 0.0475 | 24.74842126706 | 1.59225 |
| ProShares Ultra Nasdaq Biotechnology | 0.06686 | 51.697637072723 | 0.85651 |
| Range Cancer Therapeutics ETF | 1.26796 | 47.24446537918 | 0.11955 |
| Dimensional U.S. Core Equity 2 ETF | 0.00299 | 30.755198832543 | 1.47098 |
| Dimensional U.S. Targeted Value ETF | 0.01459 | 26.007247921552 | 1.93487 |
| Dimensional US Core Equity Market ETF | 0.00222 | 30.983243755928 | 1.40618 |
| Dimensional U.S. Equity ETF | 0.00101 | 31.530984204131 | 1.3557 |
| Vanguard ESG U.S. Stock ETF | 0 | 32.395678092399 | 1.26927 |
| Fidelity MSCI Health Care Index ETF | 0.01424 | 13.390080209527 | 1.46057 |
| Goldman Sachs ActiveBeta US Small Cap Equity ETF | 0.01964 | 31.359936575053 | 1.41955 |
| ProShares Hedge Replication ETF | 0.00461 | 5.9237999659878 | 1.47892 |
| Humankind US Stock ETF | 0.00452 | 18.809430395549 | 1.99919 |
| Invesco Nasdaq Biotechnology ETF | 0.1004 | 28.578975171685 | 0.8565 |
| iShares Morningstar Small-Cap ETF | 0.01505 | 30.095066471445 | 1.60498 |
| iShares Morningstar Small-Cap Growth ETF | 0.02976 | 33.628071953382 | 0.72598 |
| iShares Russell 3000 ETF | 0.00101 | 32.57283798366 | 1.43482 |
| iShares Morningstar Small-Cap ETF | 0.01505 | 391.25300933451 | 1.60498 |
| iShares Morningstar Small-Cap Growth ETF | 0.02976 | 680.05582339508 | 0.72598 |
| Direxion Daily S&P Biotech Bull 3x Shares | 0.12386 | 4067.9190751445 | 0.25924 |
| TrueShares Technology, AI & Deep Learning ETF | 1.02465 | 24.669836238774 | 0.0924 |
| Invesco FTSE RAFI US 1500 Small-Mid ETF | 0.02179 | 35.452103849597 | 1.75869 |
| Schwab U.S. Small-Cap ETF | 0.02126 | 34.281650071124 | 1.51433 |
| Schwab U.S. Broad Market ETF | 0.00108 | 32.5 | 1.43354 |
| SPDR Portfolio MSCI Global Stock Market ETF | 0.00525 | 23.600605143722 | 2.19607 |
| ProShares UltraPro Russell2000 | 0.01612 | 89.821266282945 | 1.47873 |
| Vanguard Russell 3000 ETF | 0 | 31.87314172448 | 1.43817 |
| Vanguard Russell 2000 ETF | 0.03 | 35.648084105685 | 1.48801 |
| Principal Healthcare Innovators ETF | 0.09706 | 618.4964157054 | 0.8416 |
| Future Tech ETF | 0.09706 | 426.33969118983 | 0.8416 |
| Supervisor | Cargo | Pagamento | Ano de nascimento |
|---|---|---|---|
| Mr. Brian R. Adams J.D. | Chief Legal Officer & Secretary | 598.53k | 1974 (50 anos) |
| Mr. Thomas Catinazzo | Chief Financial Officer | 599.83k | 1977 (47 anos) |
| Mr. Peter Rahmer | Chief Corporate Development Officer | 570.52k | |
| Mr. Alexis A. Borisy A.M. | Co-Founder & Independent Chairman | 85k | 1972 (52 ano) |
| Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS | CEO, President & Director | 1.03M | 1974 (50 anos) |
| Dr. Mark Murcko Ph.D. | Co-Founder & Director | 50k | 1960 (64 ano) |
| Dr. Donald A. Bergstrom M.D., Ph.D. | President of Research & Development | 711.25k | 1972 (52 ano) |
| Ms. Dorothee Kern Ph.D. | Founder | ||
| Dr. David Elliot Shaw Ph.D. | Founder | 1951 (73 ano) | |
| Mr. Matthew P. Jacobson Ph.D. | Founder |
Endereço: United States, Cambridge, MA , 399 Binney Street - abrir no Google Maps, abrir mapas Yandex
Site: http://www.relaytx.com
Site: http://www.relaytx.com
